NYSE:EVH

Stock Analysis Report

Executive Summary

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States.


Snowflake Analysis

Fair value with mediocre balance sheet.


Similar Companies

Share Price & News

How has Evolent Health's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: EVH's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

12.9%

EVH

-0.5%

US Healthcare Services

2.4%

US Market


1 Year Return

-57.3%

EVH

13.5%

US Healthcare Services

-10.0%

US Market

Return vs Industry: EVH underperformed the US Healthcare Services industry which returned 13.5% over the past year.

Return vs Market: EVH underperformed the US Market which returned -10% over the past year.


Shareholder returns

EVHIndustryMarket
7 Day12.9%-0.5%2.4%
30 Day-27.2%-4.9%-11.0%
90 Day-43.8%-1.8%-19.4%
1 Year-57.3%-57.3%13.8%13.5%-8.1%-10.0%
3 Year-74.9%-74.9%63.5%62.6%17.3%9.6%
5 Yearn/a42.1%40.7%36.1%21.1%

Price Volatility Vs. Market

How volatile is Evolent Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Evolent Health undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: EVH ($5.42) is trading below our estimate of fair value ($18.35)

Significantly Below Fair Value: EVH is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: EVH is unprofitable, so we can't compare its PE Ratio to the Healthcare Services industry average.

PE vs Market: EVH is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate EVH's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: EVH is good value based on its PB Ratio (0.5x) compared to the US Healthcare Services industry average (3x).


Next Steps

Future Growth

How is Evolent Health forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?

92.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: EVH is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: EVH is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: EVH is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: EVH's revenue (11.3% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: EVH's revenue (11.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if EVH's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Evolent Health performed over the past 5 years?

-49.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: EVH is currently unprofitable.

Growing Profit Margin: EVH is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: EVH is unprofitable, and losses have increased over the past 5 years at a rate of -49.3% per year.

Accelerating Growth: Unable to compare EVH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EVH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (23.3%).


Return on Equity

High ROE: EVH has a negative Return on Equity (-32.89%), as it is currently unprofitable.


Next Steps

Financial Health

How is Evolent Health's financial position?


Financial Position Analysis

Short Term Liabilities: EVH's short term assets ($228.8M) exceed its short term liabilities ($192.8M).

Long Term Liabilities: EVH's short term assets ($228.8M) do not cover its long term liabilities ($376.2M).


Debt to Equity History and Analysis

Debt Level: EVH's debt to equity ratio (31.6%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if EVH's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: EVH has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if EVH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Evolent Health's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate EVH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate EVH's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if EVH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if EVH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of EVH's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.2yrs

Average management tenure


CEO

Frank Williams (52yo)

8.67s

Tenure

US$3,311,000

Compensation

Mr. Frank John Williams co-founded Evolent Health, Inc. in 2011 and serves as its Chief Executive Officer since August 2011. Mr. Williams is a Director at Business Talent Group, LLC and Peer Health Exchang ...


CEO Compensation Analysis

Compensation vs Market: Frank's total compensation ($USD3.31M) is above average for companies of similar size in the US market ($USD2.18M).

Compensation vs Earnings: Frank's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Frank Williams
Co-Founder8.67yrsUS$3.31m0.75% $3.5m
Seth Blackley
Co-Founder2yrsUS$2.21m0.077% $352.3k
Thomas Peterson
Co-Founder & COO9.25yrsUS$1.09m0.031% $144.0k
Jonathan Weinberg
Chief Legal Officer4.17yrsUS$636.00k0.024% $108.6k
Norman Payson
0.83yrUS$430.46k0.019% $85.8k
Nicholas McGrane
Executive Vice President of Corporate Performance0.75yrUS$1.01m0.018% $83.2k
John Johnson
Chief Financial Officer0.75yrno data0.11% $525.3k
Lydia Stone
VP, Chief Accounting Officer & Corporate Controller4.58yrsno data0.016% $71.8k
Bob East
Investor Contactno datano datano data
Jordan Flynn
VP & Chief Compliance Officer3.67yrsno datano data

4.2yrs

Average Tenure

50yo

Average Age

Experienced Management: EVH's management team is considered experienced (4.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Frank Williams
Co-Founder8.67yrsUS$3.31m0.75% $3.5m
Seth Blackley
Co-Founder2yrsUS$2.21m0.077% $352.3k
Peter Grua
Directorno datano datano data
Bruce Felt
Presiding Directorno dataUS$195.00k0.025% $115.4k
Michael D'Amato
Independent Director4yrsUS$175.00k0.063% $288.4k
Cheryl Scott
Independent Director4.42yrsUS$175.00k0.017% $80.2k
Diane Holder
Director8.67yrsUS$190.00k0.025% $115.4k
Kenneth Samet
Independent Director4.58yrsUS$175.00k0.030% $135.9k
Mary Duffy
Independent Director2.58yrsUS$175.00k0.014% $65.8k
David Farner
Director5.58yrsUS$175.00k0.025% $115.4k

4.4yrs

Average Tenure

61yo

Average Age

Experienced Board: EVH's board of directors are considered experienced (4.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.5%.


Top Shareholders

Company Information

Evolent Health, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Evolent Health, Inc.
  • Ticker: EVH
  • Exchange: NYSE
  • Founded: 2011
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$459.196m
  • Shares outstanding: 84.72m
  • Website: https://www.evolenthealth.com

Number of Employees


Location

  • Evolent Health, Inc.
  • 800 North Glebe Road
  • Suite 500
  • Arlington
  • Virginia
  • 22203
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
EVHNYSE (New York Stock Exchange)YesClass A Common StockUSUSDJun 2015
9EHDB (Deutsche Boerse AG)YesClass A Common StockDEEURJun 2015

Biography

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; delivery network alignments; and integrated cost and revenue management solutions. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/04/08 09:21
End of Day Share Price2020/04/07 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.